Alvarez Garijo J A, Vilches J J, Aznar J A
J Neurosurg. 1980 Apr;52(4):453-5. doi: 10.3171/jns.1980.52.4.0453.
The fibrinolytic activity in cerebrospinal fluid has been monitored by determination of levels of fibrin split products (FSP) in 23 patients with ruptured intracranial aneurysms. In 20 of these 23, FSP was found in the cerebrospinal fluid (CSF), with levels ranging from 10 to 80 micrograms/ml. Eleven of the 23 patients were treated with 2 gm tranexamic acid daily. In these patients FSP was found in only two cases during the 2nd week, while in 12 untreated patients it was found in 10 cases. These results suggest that there exists a localized fibrinolytic activity, and monitoring the FSP levels in the CSF may be a simple and accurate method for controlling the efficiency of antifibrinolytic therapy. Thus, treatment could be begun with a lower dose, which could be increased later as deemed necessary from the results of careful monitoring.
通过测定23例颅内动脉瘤破裂患者脑脊液中纤维蛋白裂解产物(FSP)的水平,对脑脊液中的纤溶活性进行了监测。在这23例患者中,有20例脑脊液中发现了FSP,其水平在10至80微克/毫升之间。23例患者中有11例每天接受2克氨甲环酸治疗。在这些患者中,仅在第2周有2例发现FSP,而在12例未治疗的患者中有10例发现FSP。这些结果表明存在局部纤溶活性,监测脑脊液中FSP水平可能是控制抗纤溶治疗效果的一种简单而准确的方法。因此,可以开始用较低剂量治疗,随后可根据仔细监测的结果在必要时增加剂量。